[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2018_1718-erwgr-7-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":32,"citing_decisions":43,"is_thin":44},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2018_1718","zur Änderung der Verordnung (EG) Nr. 726\u002F2004 in Bezug auf den Sitz der Europäischen Arzneimittel-Agentur","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2025-02-13","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32018R1718",7066394,"ErwGr. 7","erwgr-7",null,"Erwägungsgründe","Die Verordnung (EG) Nr. 726\u002F2004 des Europäischen Parlaments und des Rates (3) sollte daher entsprechend geändert werden —","REG_2018_1718 - Erwägungsgründe - ErwGr. 7\n\nDie Verordnung (EG) Nr. 726\u002F2004 des Europäischen Parlaments und des Rates (3) sollte daher entsprechend geändert werden —",{},[23,26,29],{"norm_key":24,"title":17,"slug":25},"ErwGr. 6","erwgr-6",{"norm_key":27,"title":17,"slug":28},"ErwGr. 5","erwgr-5",{"norm_key":30,"title":17,"slug":31},"ErwGr. 4","erwgr-4",[33,36,40],{"norm_key":34,"title":17,"slug":35},"Art. 1","art-1",{"norm_key":37,"title":38,"slug":39},"Art. 71a","Die Agentur hat ihren Sitz in Amsterdam, Niederlande.","art-71a",{"norm_key":41,"title":17,"slug":42},"Art. 2","art-2",[],true]